Clinical Trials Logo
  1. Home
  2. Hypertension
  3. NCT04398771
  4. Details
NCT04398771 Clinical Trial

To Evaluate Safety and Effectiveness of RovatitanTab.

Hypertension Clinical Trial

Official title:
A Multicenter, Single-arm, Prospective, Observational Study to Evaluate the Safety and Effectiveness of a Fixed-dose Combination Containing Valsartan and Rosuvastatin (Rovatitan® Tablet) in Patient With Hypertension and Hypercholesterolemia

Clinical Trial Details — Status: Not yet recruiting

Administrative data
NCT number NCT04398771
Other study ID # LG-VROS001
Secondary ID
Status Not yet recruiting
Phase
First received
Last updated
Start date September 1, 2020
Est. completion date May 31, 2022

Study information
Verified date May 2020
Source LG Chem
Contact songyi Park
Phone =82-2-6987-4195
Email songyi-park@lgchem.com
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

To evaluate the safety and effectiveness of a fixed-dose combination containing valsartan and rosuvastatin (Rovatitan® Tablet) in patient with hypertension and hypercholesterolemia

Description:

- Effectiveness: the ratio of patients who reach target BP or LDL-cholesterol

- Safety: we will collect safety data

Recruitment information / eligibility
Status Not yet recruiting
Enrollment 1000
Est. completion date May 31, 2022
Est. primary completion date January 31, 2022
Accepts healthy volunteers No
Gender All
Age group 19 Years and older
Eligibility Inclusion Criteria:

- Patients who have hypertension and hyperlipidemia and older than 19 years

- Patients who undertstand purpose and method of study, agree with study

Exclusion Criteria:

- Patients who have been administered Rosuvastatin/Valsartan as a anti- hyperlipiddemic/anti-hypertensive drugs

- Uncontrolled hypertension (SBP>=180mmHg or DBP>=110mmHg)

- Patients who participated another clinical study or observational study 3 months ago.

Study Design

Related Conditions & MeSH terms

Intervention

Drug:
• Rosuvastatin/Valsartan
Rovatitan QD for 12 weeks

Locations
Country Name City State
n/a

Sponsors (1)
Lead Sponsor Collaborator
LG Chem

Outcome
Type Measure Description Time frame Safety issue
Primary The ratio of patients who reach the target BP SBP/DBP<140/90mmHg (<60years), SBP/DBP<150/90mmHg (>=60years) 12weeks
Primary The ratio of patients who reach the target LDLcholesterol target LDL refered to Hyperlipidemia pharmacotherapy 12weeks
Secondary The ratio of patients who reach the target BP and LDL-c SBP/DBP<140/90mmHg (<60years), SBP/DBP<150/90mmHg (>=60years), target LDL 12weeks
See also
  Status Clinical Trial Phase
Terminated NCT04591808 - Efficacy and Safety of Atorvastatin + Perindopril Fixed-Dose Combination S05167 in Adult Patients With Arterial Hypertension and Dyslipidemia Phase 3
Recruiting NCT04515303 - Digital Intervention Participation in DASH
Completed NCT05433233 - Effects of Lifestyle Walking on Blood Pressure in Older Adults With Hypertension N/A
Completed NCT05491642 - A Study in Male and Female Participants (After Menopause) With Mild to Moderate High Blood Pressure to Learn How Safe the Study Treatment BAY3283142 is, How it Affects the Body and How it Moves Into, Through and Out of the Body After Taking Single and Multiple Doses Phase 1
Completed NCT03093532 - A Hypertension Emergency Department Intervention Aimed at Decreasing Disparities N/A
Completed NCT04507867 - Effect of a NSS to Reduce Complications in Patients With Covid-19 and Comorbidities in Stage III N/A
Completed NCT05529147 - The Effects of Medication Induced Blood Pressure Reduction on Cerebral Hemodynamics in Hypertensive Frail Elderly
Recruiting NCT06363097 - Urinary Uromodulin, Dietary Sodium Intake and Ambulatory Blood Pressure in Patients With Chronic Kidney Disease
Recruiting NCT05976230 - Special Drug Use Surveillance of Entresto Tablets (Hypertension)
Completed NCT06008015 - A Study to Evaluate the Pharmacokinetics and the Safety After Administration of "BR1015" and Co-administration of "BR1015-1" and "BR1015-2" Under Fed Conditions in Healthy Volunteers Phase 1
Completed NCT05387174 - Nursing Intervention in Two Risk Factors of the Metabolic Syndrome and Quality of Life in the Climacteric Period N/A
Completed NCT04082585 - Total Health Improvement Program Research Project
Recruiting NCT05121337 - Groceries for Black Residents of Boston to Stop Hypertension Among Adults Without Treated Hypertension N/A
Withdrawn NCT04922424 - Mechanisms and Interventions to Address Cardiovascular Risk of Gender-affirming Hormone Therapy in Trans Men Phase 1
Active, not recruiting NCT05062161 - Sleep Duration and Blood Pressure During Sleep N/A
Completed NCT05087290 - LOnger-term Effects of COVID-19 INfection on Blood Vessels And Blood pRessure (LOCHINVAR)
Not yet recruiting NCT05038774 - Educational Intervention for Hypertension Management N/A
Completed NCT05621694 - Exploring Oxytocin Response to Meditative Movement N/A
Completed NCT05688917 - Green Coffee Effect on Metabolic Syndrome N/A
Recruiting NCT05575453 - OPTIMA-BP: Empowering PaTients in MAnaging Blood Pressure N/A